Summit Therapeutics plc (SMMT) Declined -5.56% or -0.08 To Price $1.36 On Wednesday


Summit Therapeutics plc (SMMT) declined -5.56% or -0.08 to $1.36. It is approximately 69203 shares traded, which is 223.37% compare to the average total volume 30981. The market cap of SMMT is $43.65 million. The year to date change is 14.44%. The 52 week price range is from $1.1 to $13.39. Price of SMMT have changed -5.26% during last week. It have changed -18.64% over last month, -28.00% over last 3 months, 3.59% over last 6 months and -88.85% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for SMMT is 1.75. It is 28.68% above current price. The 200-day Moving Averages for SMMT is 1.72. It is 26.47% above current price. The 52-week High is 13.39. It is 884.56% from the current price. The 52-week Low is 1.1. It is -19.12% from current price.

There are some statistics of SMMT. It is has market cap $43.65 million. The share outstanding is 32.10 million. The average volume is 30981. The percent of top 15 Institution holding is 7.10%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of SMMT is 38.25%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of SMMT is 13.24%.


Tags:

Share this post